The invention relates to histidine-rich glycoprotein (HRGP) polypeptides and the use of these polypeptides. The invention includes methods for the inhibition of angiogenesis by administering an HRGP polypeptide. The invention also includes pharmaceutical compositions and articles of manufacture comprising HRGP polypeptides, antibodies and receptors that bind to an HRGP polypeptide, HRGP-depleted plasma and polynucleotides, vectors and host cells that encode HRGP polypeptides.

 
Web www.patentalert.com

< Polynucleotide encoding an il-29 polypeptide

> .omega.-Cycloalkyl 17-heteroaryl prostaglandin E.sub.2 analogs as EP.sub.2-receptor agonists

> Synthesis of N.sup.2-(substituted arylmethyl)-3-(substituted phenyl)indazoles as novel anti-angiogenic agents

~ 00534